SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Lifesciences - Quaterly Results

12 Feb 2025 Evaluate
The revenue for the December 2024 quarter is pegged at Rs. 828.76 millions, about 16.35% up against Rs. 712.27 millions recorded during the year-ago period.The Profit  for the quarter ended December 2024 of  Rs. 62.28  millions  grew by 87.87% from Rs. 33.15 millions.Operating profit surged to 131.30 millions from the corresponding previous quarter of 96.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 828.76 712.27 16.35 2479.43 2136.28 16.06 3000.02 3152.42 -4.83
Other Income 0.61 6.40 -90.47 17.47 15.58 12.13 38.37 28.82 33.14
PBIDT 131.30 96.63 35.88 403.82 251.76 60.40 382.68 292.88 30.66
Interest 19.56 20.45 -4.35 60.40 63.43 -4.78 89.02 50.94 74.75
PBDT 111.74 76.18 46.68 343.42 188.33 82.35 293.66 265.46 10.62
Depreciation 25.64 25.46 0.71 76.35 76.29 0.08 102.54 81.73 25.46
PBT 86.10 50.72 69.76 267.07 112.04 138.37 191.12 183.73 4.02
TAX 23.82 17.57 35.57 80.11 40.73 96.69 60.47 51.55 17.30
Deferred Tax 0.71 2.57 -72.37 2.00 7.73 -74.13 19.94 20.05 -0.55
PAT 62.28 33.15 87.87 186.96 71.31 162.18 130.65 132.18 -1.16
Equity 30.23 30.23 0.00 30.23 30.23 0.00 30.23 30.23 0.00
PBIDTM(%) 15.84 13.57 16.78 16.29 11.78 38.20 12.76 9.29 37.30

Haleos Labs Share Price

1249.90 0.00 (0.00%)
08-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×